Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Halozyme Therapeutics and Pfizer to develop recombinant human hyaluronidase biologics

Dec. 27, 2012

Biogen Idec forms research consortium to develop new ALS treatments

Dec. 21, 2012

RaQualia and Lilly to extend research term of ion channel collaboration

Dec. 21, 2012

GlycoVaxyn and GSK enter collaboration to develop new bacterial vaccines

Dec. 20, 2012

UMN Pharma signs license agreement with Ildong Pharmaceutical for influenza vaccines

Dec. 20, 2012

Amgen licenses rights to TAP technology for third cancer target

Dec. 20, 2012

Arrowhead and Shire enter agreement to develop peptide-targeted therapeutics

Dec. 20, 2012

Co-development agreement reached for NTCell for Parkinson's disease

Dec. 19, 2012

Lorus Therapeutics and Brock University to develop novel anticancer drugs

Dec. 19, 2012

Lundbeck to divest non-core products to Recordati

Dec. 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...